SXT Pharmaceuticals - SXTC Company Net Assets

Public company logo of SXT China (SXTC)

China SXT Pharmaceuticals (SXTC) maintains a high reputation by synthesizing long-standing traditions of Eastern medicine with rigorous quality regulations. This price chart demonstrates the asset's dynamics, with a value of 25.80. The business minimizes risks by producing both classic herbal preparations and modern medications. Stable domestic interest in medical innovations makes the company a defensive asset independent of global crises.

SXTC - China SXT Pharmaceuticals, Inc. Book Capitalization over the range 07/04/2022 - 10/29/2026
Mass-produced product of sxtchina.com

Steady demand for traditional phytopharmaceuticals ensures stable operating cash flows for China SXT Pharmaceuticals (SXTC). By analyzing capital dynamics via the balance sheet, an investor can determine the actual value of net assets. This figure is calculated as the difference between total assets and all of the issuer's liabilities. This metric allows for the tracking of asset preservation and the exclusion of hidden write-offs. Growth in this value confirms the financial strength of the business despite limited technological barriers.

Competitor analysis for China SXT Pharmaceuticals

Haleon Corp - Total Net Assets|KVUE: Book Capitalization|Company Net Assets veronapharma.com|Company Book Value Jyong Biotech|Ligand Pharmaceuticals Incorporated - Net Asset Value|Book Capitalization AMRX|PRGO (Perrigo Corp) - Accounting Value of Company|Book Capitalization ALVO (Alvotech)|Book Capitalization liquidia.com LQDA|GLPG - Company Book Value|Accounting Value of Company ANIP (ANI Pharmaceuticals Inc)|MannKind Corp. (MNKD) - Company Book Value|Company Net Assets Amphastar Corp|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com|Company Net Assets TBPH (Theravance Biopharma, Inc.)|AQST (Aquestive Therapeutics Inc) - Accounting Value of Company|Company Book Value scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Total Stockholders' Equity|TNXP: Company Net Assets|Eupraxia Pharmaceuticals - Total Net Assets|BHST: Book Capitalization|Invizyne Technologies - Accounting Value of Company|ORMP (Oramed) - Book Capitalization|Total Stockholders' Equity Entera Bio Corp ENTX|Company Book Value MindWalk Holdings (HYFT)|ABVC (abvcpharma.com) - Accounting Value of Company|Book Capitalization CPIX (Cumberland Pharmaceuticals Inc.)|QNTM - Company Net Assets|FibroGen Corp - Book Capitalization|Accounting Value of Company TELO (Telomir Pharmaceuticals Corp)|RANI: Book Capitalization|SNYR - Book Valuation of Business|Company Book Value Rallybio Corp|Accounting Capitalization LEXX (Lexaria)|Book Capitalization PULM|Book Capitalization ftzy.com.cn (PTHL)|Aptorum Group - Company Net Assets|Accounting Value of Company LYRA|IBO - Company Book Value|Book Valuation of Business TNF Pharmaceuticals TNFA|YCBD (cbdmd.com) - Company Net Assets|Accounting Capitalization PRFX|Company Net Assets CYTO|LIPO (lipella.com) - Total Net Assets|Company Net Assets OPTN (OptiNose)|PIRS (Pieris Pharmaceuticals Inc) - Accounting Value of Company|Company Book Value Procaps Group SA PROC|PTPI (Petros Pharma) - Net Asset Value|Qilian International - Book Capitalization|Accounting Value of Company SLRN (acelyrin.com)|TFFP: Book Capitalization